WASHINGTON (GenomeWeb) – The first results from the American Association for Cancer Research's Project GENIE (Genomics Evidence Neoplasia Information Exchange) have upheld some of the hopes and expectations for this type of large-scale data-sharing effort — yielding new insights into the landscape of mutations across cancers and how they influence patient response to targeted therapies.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.